Xconomy: MDRNA Nabs $7.25M From Novartis

E-mail a copy of 'MDRNA Nabs $7.25M From Novartis' to a friend

Loading ...

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper

Potency Assay Development for Cell and Gene Therapy Products

Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper

What’s Next in Neuroscience Therapies

New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper

How to Approach Life Sciences Fundraising

Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!